关于先锋

Company Profile

Pioneer Information

Notice Announcement

Industry News

Environmental information disclosure

Jilin

Release time:

2023-07-24

Common name Specifications Packaging
Ambroxol Hydrochloride Capsules 60mg 24 capsules/box
Ambroxol Hydrochloride Capsules 30mg 36 capsules/box
Ambroxol Hydrochloride Capsules 30mg 12 capsules/box
Ambroxol Hydrochloride Capsules 60mg 12 capsules/box
Ambroxol Hydrochloride Capsules 30mg 24 capsules/box
Clindamycin Phosphate for Injection 0.3g 1 piece/box
Cefoxitin Sodium for Injection 0.5g 1 bottle/box
Guipi Capsule 0.3g per capsule 24 capsules/box
Clindamycin Phosphate for Injection 0.6g 1 piece/box
Diammonium glycyrrhizinate enteric-coated tablets 50mg 24 pieces/box
Clindamycin hydrochloride for injection 0.15g 1 bottle/box
Sodium fructose diphosphate for injection 5g 1 bottle/bottle
Fenofibrate Capsules 0.2g 20 capsules/box
Cefazolin Sodium for Injection 0.5g 1 bottle/box
Guipi Capsule 0.3g per capsule 36 capsules/box
Anetellithin Tablets 25mg 12pcs/box
Cefoxitin Sodium for Injection 1.0g 1 bottle/box
Azithromycin for Injection 0.5g 10 sticks/stick
Back →

Related news

2023-03-08

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

2023-02-27

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

2023-02-25

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs